Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Sesen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Neurology|April 19, 2021
Non-invasive Urinary Biomarkers in Moyamoya DiseaseJulie Sesen, Jessica Driscoll, Alexander Moses-Gardner, et al.
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
The Bad, the Good and eIF3e/INT6Julie Sesen, Joshua Casaos, Sarah J Scotland, et al.
Scientific Reports|November 7, 2023
Disease specific urinary biomarkers in the central nervous systemMicah Duggins-Warf, Aram Ghalali, Julie Sesen, et al.
Cellular and Molecular Neurobiology|December 27, 2023
Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell PathophysiologyJulie Sesen, Aram Ghalali, Jessica Driscoll, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 18, 2025
AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotypeJulie Sesen, Tyra Martinez, Sara Busatto, et al.
Journal of Neurosurgery. Pediatrics|January 30, 2026
Cell division cycle 42 binding protein beta as a plasma-based biomarker for cerebral cavernous malformationsYousef Hattar, Julie Sesen, Tyra Martinez, et al.
Frontiers in Neuroscience|September 5, 2024
Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatmentKarthik Ashok, Tyra Martinez, Julie Sesen, et al.
International Journal of Molecular Sciences|February 1, 2014
Int6/eIF3e is essential for proliferation and survival of human glioblastoma cellsJulie Sesen, Anne Cammas, Sarah J Scotland, et al.
Oncotarget|November 22, 2017
Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an updateLaure Malric, Sylvie Monferran, Julia Gilhodes, et al.
Brain Research|February 11, 2021
Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasionJulie Sesen, Jessica Driscoll, Nishali Shah, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Neurology|April 19, 2021
Non-invasive Urinary Biomarkers in Moyamoya DiseaseJulie Sesen, Jessica Driscoll, Alexander Moses-Gardner, et al.
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
The Bad, the Good and eIF3e/INT6Julie Sesen, Joshua Casaos, Sarah J Scotland, et al.
Scientific Reports|November 7, 2023
Disease specific urinary biomarkers in the central nervous systemMicah Duggins-Warf, Aram Ghalali, Julie Sesen, et al.
Cellular and Molecular Neurobiology|December 27, 2023
Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell PathophysiologyJulie Sesen, Aram Ghalali, Jessica Driscoll, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 18, 2025
AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotypeJulie Sesen, Tyra Martinez, Sara Busatto, et al.
Journal of Neurosurgery. Pediatrics|January 30, 2026
Cell division cycle 42 binding protein beta as a plasma-based biomarker for cerebral cavernous malformationsYousef Hattar, Julie Sesen, Tyra Martinez, et al.
Frontiers in Neuroscience|September 5, 2024
Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatmentKarthik Ashok, Tyra Martinez, Julie Sesen, et al.
International Journal of Molecular Sciences|February 1, 2014
Int6/eIF3e is essential for proliferation and survival of human glioblastoma cellsJulie Sesen, Anne Cammas, Sarah J Scotland, et al.
Oncotarget|November 22, 2017
Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an updateLaure Malric, Sylvie Monferran, Julia Gilhodes, et al.
Brain Research|February 11, 2021
Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasionJulie Sesen, Jessica Driscoll, Nishali Shah, et al.
Pageof 2